ATC
AXSM icon

Argent Trust Co’s Axsome Therapeutics AXSM Stock Holding History

Argent Trust Co’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
+1,174
New +$255K 0.01% 658
2026
Q1 		– Sell
-1,174
Closed -$214K – 710
2025
Q4 		$214K Buy
+1,174
New +$164K 0.01% 665

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Argent Trust Co's AXSM Position: Q2 2026 in Review

Argent Trust Co opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 1,174 shares worth $287K. The stake represents 0.01% of the portfolio and ranks #658 among its holdings. This is a return to the name: Argent Trust Co previously reported a position in AXSM as recently as Q4 2025.

Argent Trust Co first reported a position in AXSM in Q4 2025 and has held it in 2 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Argent Trust Co held 1,174 shares of Axsome Therapeutics worth $287K as of Q2 2026.
  • Axsome Therapeutics was a new Argent Trust Co position in Q2 2026.
  • Axsome Therapeutics made up 0.01% of Argent Trust Co's portfolio in Q2 2026, its #658 holding.
  • Argent Trust Co first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.